Table 1.

Patient characteristics

Patient Gender Hormone Replacement Underlying Disorder Primary Therapy
Placebo
1 FT4, E Chromophobe adenoma Hypophysectomy
2 F G, T4, E AcromegalyHypophysectomy
3 F T4, E Chromophobe adenoma Hypophysectomy
4 F G Cushing’s diseaseHypophysectomy
5 M T4, G, TChromophobe adenoma Hypophysectomy
6 MT4, E, T Chromophobe adenoma Hypophysectomy
GH treatment
1 MT4, G, T Idiopathic hypopituitarism
2 F T4, G, E Chromophobe adenomaHypophysectomy
3 F E Chromophobe adenomaHypophysectomy
4 F G, E Cushing’s diseaseHypophysectomy
5 F T4, G, ESheehan’s syndrome
6 M T4, TMacroprolactinoma Hypophysectomy
  • F, female; M, male; T4, thyroxine; E, estrogen; T, testosterone; G, glucocorticoid; GH, growth hormone.